An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs. Gandullo-Sanchez L, Pandiella A. Cancer Lett 2023;554:216024.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gandullo-Sanchez L, Pandiella A. An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs. Cancer Lett 2023;554:216024.
PMID: 36455759